Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Assets Average (2016 - 2026)

Neuroone Medical Technologies filings provide 13 years of Assets Average readings, the most recent being $8.2 million for Q1 2026.

  • On a quarterly basis, Assets Average rose 50.14% to $8.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $8.2 million, a 50.14% increase, with the full-year FY2025 number at $8.1 million, up 19.96% from a year prior.
  • Assets Average hit $8.2 million in Q1 2026 for Neuroone Medical Technologies, down from $9.7 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $15.6 million in Q1 2022 to a low of $5.1 million in Q3 2024.
  • Median Assets Average over the past 5 years was $7.6 million (2025), compared with a mean of $8.5 million.
  • Biggest five-year swings in Assets Average: tumbled 49.48% in 2023 and later soared 110.11% in 2025.
  • Neuroone Medical Technologies' Assets Average stood at $11.2 million in 2022, then tumbled by 38.09% to $7.0 million in 2023, then fell by 14.77% to $5.9 million in 2024, then surged by 63.2% to $9.7 million in 2025, then dropped by 15.08% to $8.2 million in 2026.
  • The last three reported values for Assets Average were $8.2 million (Q1 2026), $9.7 million (Q4 2025), and $10.8 million (Q3 2025) per Business Quant data.